Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

Abstract

We conducted a double-blind, placebo-controlled trial of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. Although significant clinical benefit was documented (N Engl J Med 1987; 317:185–91), serious adverse reactions, particularly bone marrow suppression, were observed. Nausea, myalgia, insomnia, and severe headaches were reported more frequently by recipients of AZT; macrocytosis developed within weeks in most of the AZT group. Anemia with hemoglobin levels below 7.5 g per deciliter developed in 24 percent of AZT recipients and 4 percent of placebo recipients (P<0.001). Twenty-one percent of AZT recipients and 4 percent of placebo recipients required multiple red-cell transfusions (P<0.001). Neutropenia (<500 cells per cubic millimeter) occurred in 16 percent of AZT recipients, as compared with 2 percent of placebo recipients (P<0.001). Subjects who entered the study with low CD4 lymphocyte counts, low serum vitamin B12 levels, anemia, or low neutrophil counts were more likely to have hematologic toxic effects. Concurrent use of acetaminophen was also associated with a higher frequency of hematologic toxicity. Although a subset of patients tolerated AZT for an extended period with few toxic effects, the drug should be administered with caution because of its toxicity and the limited experience with it to date. (N Engl J Med 1987; 317:192–7.)

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198707233170402

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Research works printed but not linked: 6

  1. Mantel, 1959, JNCI, 22, 719
  2. van Eiteren, 1960, Bull Int Stat Inst, 37, 351
  3. Caballero, 1985, Cancer Treat Rep, 69, 13
  4. Good, 1986, Fed Proc, 45, 444
  5. de Miranda P. Good SS, Blum MR, et al. The effect of probenecid on the pharmacokinetic disposition of azidothymidine (AZT). Presented at the International Conference on AIDS, Paris, 1986. abstract.
  6. Orme, 1974, Clin Sci Mol Med, 46, 511

Cited by

See all 1,199

Metadata

Authors
Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., Jackson, G. G., Durack, D. T., Nusinoff-Lehrman, S., & The AZT Collaborative Working Group
Venue
New England Journal of Medicine
Published
1987-07-23
Volume
317
Issue
4
Pages
192-197
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4256221661
Cited by
1,199
References
8
Citations by year
2025: 6 · 2024: 3 · 2023: 2 · 2022: 8 · 2021: 7 · 2020: 7 · 2019: 7 · 2018: 10 · 2017: 17 · 2016: 10 · 2015: 12 · 2014: 10 · 2013: 16 · 2012: 12
FWCI
94.67
Type
journal article
Language
en
Open access
closed
Locations
New England Journal of Medicine (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
zidovudine, AIDS, AIDS-related complex, drug toxicity, myelosuppression, anemia, neutropenia, macrocytosis, hematologic adverse events, paracetamol, CD4 count, vitamin B12, red blood cell transfusion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex. https://app.cochat.ai/papers/10.1056/nejm198707233170402
The paper
Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., Jackson, G. G., Durack, D. T., Nusinoff-Lehrman, S., & The AZT Collaborative Working Group. (1987). The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex. New England Journal of Medicine. https://doi.org/10.1056/nejm198707233170402

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.